Emakalim is an ATP-dependent potassium channel agonist. Emakalim can be used in the research of gliomas, triple-negative breast cancer, non-small cell lung cancer, and colorectal cancer[1].
Molecular Weight:
296.32
CAS Number:
[129729-66-4]
Formula:
C17H16N2O3
Target:
Potassium Channel
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted